Selby MJ, Engelhardt JJ, Quigley M, Henning KA, Chen T, Srinivasan M, et al. Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity throughreduction of intratumoral regulatory T cells. Cancer Immunol Res (2013) 1(1):32 – 42. doi: 10.1158/2326-6066.CIR-13-0013 25. Simon S, Labarriere N. PD-1 expression on tumor-speci ﬁc T cells: Friend or foe for immunotherapy? Oncoimmunology (2017) 7(1):e1364828. doi: 10.1080/ 2162402X.2017.1364828 26. Gros A, Parkhurst MR, Tran E, Pasetto A, Robbins PF, Ilyas S, et al. Prospective identi ﬁcation of neoantigen-speci ﬁc lymphocytes in the peripheral blood of melanoma patients. Nat Med (2016) 22(4):433 –8.